About Oxytocin
Neuropeptide hormone binding oxytocin receptors throughout brain and body; modulates HPA axis, reduces cortisol, promotes parasympathetic tone
Oxytocin is an endogenous hypothalamic nonapeptide and FDA-approved prescription medication (Pitocin) indicated for initiation and augmentation of labor, management of postpartum uterine atony and hemorrhage, and stimulation of milk letdown in breastfeeding women, acting through peripheral oxytocin receptors in the uterus and mammary gland. Beyond its obstetric and lactation roles, oxytocin functions centrally as a neuromodulator in limbic and cortical circuits involved in social recognition, attachment, trust behavior, and fear regulation, with broadly distributed brain oxytocin receptors mediating effects distinct from its peripheral reproductive actions. A landmark randomized, double-blind trial published in Nature demonstrated that intranasal oxytocin significantly increases trust in humans, and controlled research has subsequently characterized its effects on social attention to facial cues and affective empathy, establishing the central prosocial pharmacology of the peptide in human subjects. Oxytocin is FDA-approved only for its obstetric and lactation indications; intranasal formulations for prosocial, cognitive, or psychiatric applications are investigational, and while the mechanistic rationale is established in healthy-volunteer research, no intranasal oxytocin product has received regulatory approval for any psychiatric or behavioral indication. Intranasal oxytocin in research: studies have administered intranasal oxytocin in doses of 20–40 IU, with 24 IU being the most commonly used dose in human behavioral pharmacology research. This delivery route is studied for the hypothesis that olfactory epithelium absorption provides partial access to the CNS beyond what the blood-brain barrier would permit from systemic routes. Research applications under active investigation include autism spectrum disorder (multiple RCTs examining social cognition outcomes), PTSD (fear extinction augmentation), social anxiety disorder, and borderline personality disorder — none of which has produced a regulatory-ready efficacy signal sufficient for approval as of 2025, though ongoing trial activity is substantial. Oxytocin's anti-inflammatory research profile is also documented — oxytocin receptors are expressed on immune cells and the peptide has been shown to suppress pro-inflammatory cytokine release in preclinical models, an emerging research direction that intersects with gut and systemic inflammation contexts. Telehealth providers and compounding pharmacies offering oxytocin formulations for clinical contexts are listed in the PeptideBase directory.
Oxytocin Benefits & Research Areas
Research Signals
Commonly researched in the context of
Population research notes
These signals reflect research interest areas, not treatment indications.
Regulatory & Evidence
Risk Profile
Generally considered lower risk in research contexts. Risk profile varies by individual — review contraindications before use.
Regulatory Status
- Availability Status
- Prescription
- FDA Status
- FDA Approved
FDA-approved oxytocic hormone. Brand: Pitocin (NDA 016992 and generics). Indicated for labor induction and postpartum hemorrhage. Also on FDA 503A Category 1 compounding list. Prescription only.
Regulatory status reflects publicly available information and may change. This is not legal or medical advice.
Research Sources
7 sources cited · 1 strong · 6 moderate
2 RCTs · 5 Cohorts
Oxytocin increases trust in humans
Nature · 2005
Research in a randomized double-blind trial found that intranasal oxytocin 24 IU substantially increased the willingness of participants to trust strangers in a financial decision task compared with placebo, with no increase in general risk-taking behavior, identifying a specific prosocial effect on trust mediated by oxytocin's central nervous system actions.
Oxytocin attenuates respiratory depression and reduces mortality from fentanyl and the combination of xylazine-fentanyl in rats.
Biomed Pharmacother · 2026
# Research Summary Research found that oxytocin improved survival and restored respiratory function in rats experiencing opioid-induced respiratory depression from fentanyl alone and from the combination of fentanyl and xylazine. This study demonstrated that oxytocin's effects were significantly greater than naloxone's recovery in the fentanyl-xylazine combination, suggesting oxytocin as a promising therapeutic target for opioid-related respiratory depression, particularly in cases where naloxone is only partially effective.
Pituitary Neurolobectomy induces sustained hypotension in male Wistar rats and normalizes blood pressure in male spontaneously hypertensive rats.
Physiol Rep · 2026
# Summary This study demonstrated that removal of the neurointermediate pituitary lobe—which caused sustained deficiency of both vasopressin and oxytocin—produced sustained blood pressure reduction in normal rats and normalized elevated blood pressure in hypertensive rats. These findings indicate that vasopressin plays a critical role in regulating blood pressure under both normal and hypertensive conditions.
Show 4 more sources ↓
Optical insights into spatial precision and release heterogeneity of neuromodulatory transmission.
iScience · 2026
# Summary Research found that oxytocin and other neuromodulatory transmitters exhibit spatially precise, heterogeneous release patterns at the synapse, rather than the previously assumed slow and diffuse transmission. This study demonstrated that advanced optical imaging techniques can now measure neuromodulator release with near single-synapse resolution, revealing striking variability in release properties across different neuronal types and compartments that may explain how a single transmitter can mediate distinct physiological and behavioral functions.
Changes in milk yield, composition, and udder morphology during early lactation according to weaning management period in Sicilo-Sarde ewes.
Trop Anim Health Prod · 2026
# Summary This study demonstrated that researchers observed that semi-early weaning (at 45-50 days) and late weaning (at 60-70 days) of lambs resulted in significantly higher milk yield in Sicilo-Sarde ewes compared to early weaning (at 30-35 days), while milk composition and quality remained comparable across all weaning systems. Research found that delaying weaning increased the volume of milk available for collection without compromising nutritional properties, suggesting semi-early weaning as a practical management strategy to enhance milk production on farms.
Retained fetal membranes in light breed mares hospitalized for attended parturition.
J Equine Vet Sci · 2026
# Summary Research found that retained fetal membranes (RFM) occurred in 17% of hospitalized light breed mares, with significantly higher rates following dystocia (difficult birth) compared to normal parturition, and was strongly associated with postpartum metritis (uterine inflammation). This study demonstrated that approximately 65% of affected mares responded successfully to standard treatment protocols, though the condition's multifactorial nature suggests additional factors beyond dystocia warrant further investigation.
Oxytocin increases attention to the eyes and selectively enhances self-reported affective empathy for fear
Neuropsychologia · 2017
Research in a double-blind randomized crossover trial found that intranasal oxytocin 24 IU increased time spent fixating on the eye region of faces across emotional contexts and selectively enhanced self-reported affective empathy for fearful expressions, supporting a role for oxytocin in social attention and emotional processing.
Oxytocin Side Effects & Safety Considerations
Generally considered lower risk in research contexts. Individual response varies — review all considerations before use.
Reported contraindications & considerations
Consult a qualified healthcare professional before making any health decisions. This information is educational only and does not constitute medical advice.
Known Interactions
1 notedResearch suggests PT-141 and Oxytocin may produce complementary sexual health effects when combined. PT-141 activates central melanocortin receptors involved in arousal signaling, while oxytocin modulates bonding, reward, and peripheral reproductive pathways.
Pfaus JG et al. (2007) The biology and psychology of sexual arousal. J Sex Med; Carmichael MS et al. (1987) Plasma oxytocin increases in the human sexual response. J Clin Endocrinol Metab
These interactions reflect published research and are provided for educational purposes only. This is not medical advice. Consult a qualified healthcare professional before combining any compounds or medications.
Where to Buy Oxytocin — Providers & Availability
66 providersClinics
7 providersCompounding Pharmacies (503A)
2 providersOnline Vendors
1 providerStay updated on verified Oxytocin providers
New verified providers added weekly — delivered to your inbox.
Questions to Ask Your Provider
Frequently Asked Questions — Oxytocin
Oxytocin is an endogenous hypothalamic nonapeptide and FDA-approved prescription medication (Pitocin) indicated for initiation and augmentation of labor, management of postpartum uterine atony and hemorrhage, and stimulation of milk letdown in breastfeeding women, acting through peripheral oxytocin receptors in the uterus and mammary gland. Beyond its obstetric and lactation roles, oxytocin functions centrally as a neuromodulator in limbic and cortical circuits involved in social recognition, attachment, trust behavior, and fear regulation, with broadly distributed brain oxytocin receptors mediating effects distinct from its peripheral reproductive actions.
prosocial and trust behavior — landmark RCT evidence in humans, social recognition, attachment, and fear circuit modulation, FDA-approved obstetric use (Pitocin) — labor initiation and postpartum hemorrhage, investigational intranasal 20–40 IU protocols for ASD, PTSD, and social anxiety research.
Research on Oxytocin primarily documents effects related to prosocial and trust behavior — landmark RCT evidence in humans and social recognition, attachment, and fear circuit modulation and FDA-approved obstetric use (Pitocin) — labor initiation and postpartum hemorrhage and investigational intranasal 20–40 IU protocols for ASD, PTSD, and social anxiety research. These are areas covered in preclinical and clinical literature — individual response varies and effects depend on context of use.
Reported contraindications and considerations for Oxytocin include cardiovascular disease, hyponatremia risk. This is educational information only — consult a qualified healthcare professional before use.
66 providers in the directory currently offer Oxytocin.
Research in a randomized double-blind trial found that intranasal oxytocin 24 IU substantially increased the willingness of participants to trust strangers in a financial decision task compared with placebo, with no increase in general risk-taking behavior, identifying a specific prosocial effect on trust mediated by oxytocin's central nervous system actions.